Literature DB >> 7722860

Development of a short form of the adolescent version of the Defense Mechanisms Inventory.

C J Recklitis1, L Yap, G G Noam.   

Abstract

This article describes the construction of a short form of the adolescent version of the Defense Mechanisms Inventory (DMI; Gleser & Ihilevich, 1969; Ihilevich & Gleser, 1986). The DMI is a paper-and-pencil test for which subjects are asked to describe their reactions to 10 hypothetical dilemmas. The responses involve a forced choice method in which each of the alternative responses represent one of five defense clusters entitled Turning Against the Object, Principalization, Turning Against the Self, Reversal, and Projection. Two hundred ninety-five adolescent psychiatric patients (122 boys and 173 girls) ages 12-16 were administered the adolescent form of the DMI. Based on an analysis of each of the 10 dilemma stories, a 6-story short form was devised. Correlations between this short form and the long form of the DMI ranged from .90 to .95 on the five defense scales, with no significant effect of gender. Internal reliability estimates of the short form scales were also favorable. These results indicate that the short form of the adolescent DMI is an acceptable substitute for the lengthier inventory from which it was derived and is more utilizable in clinical and research settings.

Entities:  

Mesh:

Year:  1995        PMID: 7722860     DOI: 10.1207/s15327752jpa6402_14

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  2 in total

1.  Norm values and psychometric properties of the short version of the Trier Inventory for Chronic Stress (TICS) in a representative German sample.

Authors:  Katja Petrowski; Sören Kliem; Cornelia Albani; Andreas Hinz; Elmar Brähler
Journal:  PLoS One       Date:  2019-11-18       Impact factor: 3.240

2.  Psychometric properties of an English short version of the Trier Inventory for chronic Stress.

Authors:  K Petrowski; E Braehler; B Schmalbach; A Hinz; C Bastianon; T Ritz
Journal:  BMC Med Res Methodol       Date:  2020-12-16       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.